Harbright 2024 SonoVascular Series, a series of Harbright LLC — Form D
Harbright 2024 SonoVascular Series, a series of Harbright LLC of CARY, NC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-10-21. The offering totals $1.5M, of which $60K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-10-21
- Form: D
- Accession: 0002021997-25-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $1.5M
- Amount sold: $60K
- Remaining: $1.4M
- Minimum investment: $5K
- Investors: 2
- Date of first sale: 2025-10-07
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-561513
Issuer
- Name: Harbright 2024 SonoVascular Series, a series of Harbright LLC
- CIK: 0002021997
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 107 KILMAYNE DRIVE, CARY, NC, 27511
- Phone: 919-612-0729
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| John Michael Harlow | Director | Clayton, NC |
| John Powell Leachman | Director | Gainesville, GA |
| Robert Earl Ross | Director | Cary, NC |
| John Powell Leachman | Promoter | Gainesville, GA |
| Robert Earl Ross | Promoter | Cary, NC |
Other filings by this issuer (1)
More